1. Submit the intake form
Share contact details, diagnosis information, exposure history, and the campaign you want reviewed.
Lawsuits concerning talcum powder claim that manufacturers knew their products contained asbestos, potentially causing ovarian cancer and mesothelioma, yet failed to issue proper warnings to the public. While individual claims make up the bulk of filings, several class-action lawsuits have also been initiated. Plaintiffs have successfully secured billions in compensation through jury verdicts.

As of January 2026, over 90,000 lawsuits face Johnson & Johnson (J&J) alleging their talc-based baby powder causes ovarian cancer and mesothelioma due to asbestos contamination. Despite J&J's failed bankruptcy attempts to settle, recent, significant jury verdicts, including a $40 million award in December 2025, continue to hold the company liable.
Mass Litigation: More than 90,000 cases are pending, with new filings continuing.
Legal Setbacks: In December 2025, a Los Angeles jury ordered J&J to pay $40 million to two women with ovarian cancer.
International Action: In October 2025, a major lawsuit was filed in the UK representing 3,000 people, alleging J&J knew of asbestos contamination as early as the 1960s.
Bankruptcy Strategy: J&J's attempts to use the "Texas Two-Step" bankruptcy to resolve liabilities were dismissed by courts in 2023, though appeals and mediation continue.
Product Shift: J&J discontinued talc-based baby powder globally in 2023, switching to cornstarch, but maintains its products are safe.
Contamination: Plaintiffs argue that talc, which is mined near asbestos, was contaminated with carcinogenic fibers.
Cancer Links: Studies, including a 2024 NIH study, found a link between perineal talc use and ovarian cancer.
Failure to Warn: Lawsuits claim the company failed to warn consumers about the risks of using the powder for feminine hygiene.
Medical conditions such as Ovarian Cancer and Mesothelioma have been linked to usage.
Billions of dollars have been awarded in jury verdicts, including a landmark $4.69 billion judgment.
Major companies involved include Johnson & Johnson, Colgate-Palmolive, Imerys Talc America, and others.
To be eligible for ovarian cancer litigation, individuals must have used talc-based products on or around the genital area on a daily or frequent basis prior to their diagnosis. Note that products based on cornstarch are not included in these lawsuits as they do not contain talc.
If you developed mesothelioma from using cosmetic or industrial talc products—such as clay, chalk, or pottery supplies—you may also have a claim.
Talc intake reviews commonly focus on diagnosis documentation, product-use history, exposure timelines, and prior attorney or claim status so reviewers can route potentially eligible inquiries efficiently.
These official references are provided for background education only. They do not replace medical or legal advice.
Share contact details, diagnosis information, exposure history, and the campaign you want reviewed.
Gather medical records, product history, proof of exposure, and timeline information that may help reviewers understand the claim.
AMMS or an intake partner may contact you for clarifying details before any potential legal review.
Qualified legal professionals decide whether a claim can move forward. AMMS does not provide legal advice or guarantee results.
Diagnosis details, talc product history, use dates, treatment records, and prior claim or attorney status help reviewers understand the intake request.
No. Submitting intake information is a review step only. Representation begins only if a qualified legal professional agrees to accept a claim.